Literature DB >> 35463708

Visceral and renal protection in thoracoabdominal aortic surgery.

Cuddalore Sadasivan Vijayashankar1, George Jose Valooran2.   

Abstract

Ischemic renal failure and visceral ischemia are two serious complications of the surgery for thoracoabdominal aortic aneurysm. The introduction of left atrial bypass, partial bypass, total circulatory arrest, and selective visceral perfusion has reduced the incidence of these complications over the past two decades. Yet these complications still persist, suggesting the sub-optimal nature of the available strategies. © Indian Association of Cardiovascular-Thoracic Surgeons 2021.

Entities:  

Keywords:  Renal protection; Thoracoabdominal aneurysm; Visceral ischemia

Year:  2021        PMID: 35463708      PMCID: PMC8980969          DOI: 10.1007/s12055-020-01129-2

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


  21 in total

1.  Strategies for renal and visceral protection in thoracoabdominal aortic surgery.

Authors:  Joseph S Coselli
Journal:  J Thorac Cardiovasc Surg       Date:  2010-12       Impact factor: 5.209

2.  Predictors of early and late mortality following open extent IV thoracoabdominal aortic aneurysm repair in a large contemporary single-center experience.

Authors:  Derek P Nathan; Clayton J Brinster; Edward Y Woo; Jeffrey P Carpenter; Ronald M Fairman; Benjamin M Jackson
Journal:  J Vasc Surg       Date:  2010-11-20       Impact factor: 4.268

3.  Reduction in the incidence of acute kidney injury after aortic arch surgery with low-dose atrial natriuretic peptide: a randomised controlled trial.

Authors:  Yosuke Mori; Takaaki Kamada; Ryoichi Ochiai
Journal:  Eur J Anaesthesiol       Date:  2014-07       Impact factor: 4.330

4.  The impact of selective visceral perfusion on intestinal macrohemodynamics and microhemodynamics in a porcine model of thoracic aortic cross-clamping.

Authors:  Johannes Kalder; Paula Keschenau; Sebastiaan J Hanssen; Andreas Greiner; Iris C Vermeulen Windsant; Lieven N Kennes; Rene Tolba; Fritz W Prinzen; Wim A Buurman; Michael J Jacobs; Thomas A Koeppel
Journal:  J Vasc Surg       Date:  2012-04-10       Impact factor: 4.268

5.  Serum myoglobin and renal morbidity and mortality following thoracic and thoraco-abdominal aortic repair: does rhabdomyolysis play a role?

Authors:  C C Miller; M A Villa; J Sutton; D Lau; K Keyhani; A L Estrera; A Azizzadeh; S M Coogan; H J Safi
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-02-15       Impact factor: 7.069

6.  Thoracoabdominal aortic aneurysms associated with celiac, superior mesenteric, and renal artery occlusive disease: methods and analysis of results in 271 patients.

Authors:  L G Svensson; E S Crawford; K R Hess; J S Coselli; H J Safi
Journal:  J Vasc Surg       Date:  1992-09       Impact factor: 4.268

7.  Hypothermic cardiopulmonary bypass and circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta.

Authors:  Nicholas T Kouchoukos; Paolo Masetti; Chris K Rokkas; Suzan F Murphy
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

8.  Passive Temporary Visceral Shunt from the Axillar Artery as an Adjunct Method during the Open Treatment of Thoracoabdominal Aortic Aneurysm.

Authors:  Antoine Monnot; Marie Melody Dusseaux; Sylvie Godier; Didier Plissonnier
Journal:  Ann Vasc Surg       Date:  2016-07-15       Impact factor: 1.466

9.  Reduced renal failure following thoracoabdominal aortic aneurysm repair by selective perfusion.

Authors:  M J Jacobs; L Eijsman; S A Meylaerts; R Balm; D A Legemate; P de Haan; C J Kalkman; B A de Mol
Journal:  Eur J Cardiothorac Surg       Date:  1998-08       Impact factor: 4.191

10.  Randomized comparison of cold blood and cold crystalloid renal perfusion for renal protection during thoracoabdominal aortic aneurysm repair.

Authors:  Scott A Lemaire; Marisa M Jones; Lori D Conklin; Stacey A Carter; Monique D Criddell; Xing Li Wang; Steven A Raskin; Joseph S Coselli
Journal:  J Vasc Surg       Date:  2008-11-22       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.